Penn Medicine Study Calls for Range of Diagnostic Spinal Fluid Tests to Help Clinicians Differentiate Concurrent Neurodegenerative Diseases

In a series of studies being presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans, Penn researchers demonstrated that, while tests created for AD are effectively diagnosing the condition when it's clear cut, additional tests are needed to address the many cases with mixed pathology.